SCHEMBL22817857

SCHEMBL22817857

c1ccc(-c2ccccc2N(c2cccc3ccccc23)c2cc3c(oc4cccc(-c5ccc6ccccc6c5)c43)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.35
▸ MAPT P10636 4/20 0.35
▸ CYP1A1 P04798 4/20 0.35
▸ CYP1B1 Q16678 3/20 0.35
▸ PRKDC P78527 2/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ HSD17B10 Q99714 4/20 0.33
▸ HPGD P15428 3/20 0.33
▸ TP53 P04637 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PIM1 P11309 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22817770 0.99 ALOX5 (0.35) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818219 0.95 ALOX5 (0.39) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818293 0.94 ALOX5 (0.36) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818332 0.94 ALOX5 (0.36) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22817836 0.94 ALOX5 (0.36) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818398 0.94 ALDH1A1 (0.36) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818436 0.93 ALOX5 (0.40) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818344 0.93 ALOX5 (0.36) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22818121 0.92 ALOX5 (0.34) ALOX5ALDH1A1MAPTCYP1A1CYP1B1
SCHEMBL22817728 0.91 ALDH1A1 (0.38) ALOX5ALDH1A1MAPTCYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885ALDH1A1 1915/4885MAPT 1145/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885ALDH1A1 1915/4885MAPT 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback